PubMed

Des-gamma-Carboxy Prothrombin and alpha-Fetoprotein as Biomarkers for the Early Detection of Hepatocellular Carcinoma.

Lok AS, Sterling RK, Everhart JE, Wright EC, Hoefs JC, Di Bisceglie AM, Morgan TR, Kim HY, Lee WM, Bonkovsky HL, Dienstag JL; HALT-C Trial Group.

Gastroenterology. 2009 Oct 20. [Epub ahead of print]PMID: 19852963 [PubMed - as supplied by publisher]Related articles

Public health impact of antiviral therapy for hepatitis C in the United States.

Volk ML, Tocco R, Saini S, Lok AS.

Hepatology. 2009 Dec;50(6):1750-5.PMID: 19824079 [PubMed - in process]Related articles

Predicting Clinical and Histologic Outcomes Based on Standard Laboratory Tests in Advanced Chronic Hepatitis C.

Ghany MG, Lok AS, Everhart JE, Everson GT, Lee WM, Curto TM, Wright EC, Stoddard AM, Sterling RK, Di Bisceglie AM, Bonkovsky HL, Morishima C, Morgan TR, Dienstag JL; HALT-C Trial Group.

Gastroenterology. 2009 Sep 18. [Epub ahead of print]PMID: 19766643 [PubMed - as supplied by publisher]Related articles

Prof. Ding-Shinn Chen.

Lok AS.

J Hepatol. 2009 Oct;51(4):615-6. No abstract available. PMID: 19760808 [PubMed - in process]Related articles

Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the Halt-C Trial.

Shiffman ML, Morishima C, Dienstag JL, Lindsay KL, Hoefs JC, Lee WM, Wright EC, Naishadham D, Everson GT, Lok AS, Di Bisceglie AM, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

Gastroenterology. 2009 Sep 10. [Epub ahead of print]PMID: 19747918 [PubMed - as supplied by publisher]Related articles

Renal outcomes after liver transplantation in the model for end-stage liver disease era.

Sharma P, Welch K, Eikstadt R, Marrero JA, Fontana RJ, Lok AS.

Liver Transpl. 2009 Sep;15(9):1142-8.PMID: 19718633 [PubMed - in process]Related articles

Liver transplantation outcomes among Caucasians, Asian Americans, and African Americans with hepatitis B.

Bzowej N, Han S, Degertekin B, Keeffe EB, Emre S, Brown R, Reddy R, Lok AS; National Institutes of Health Hepatitis B Virus Orthotopic Liver Transplantation Study Group.

Liver Transpl. 2009 Sep;15(9):1010-20.PMID: 19718627 [PubMed - in process]Related articles

Chronic hepatitis B: update 2009.

Lok AS, McMahon BJ.

Hepatology. 2009 Sep;50(3):661-2. No abstract available. PMID: 19714720 [PubMed - indexed for MEDLINE]Related articles

Coffee intake is associated with lower rates of liver disease progression in chronic hepatitis C.

Freedman ND, Everhart JE, Lindsay KL, Ghany MG, Curto TM, Shiffman ML, Lee WM, Lok AS, Di Bisceglie AM, Bonkovsky HL, Hoefs JC, Dienstag JL, Morishima C, Abnet CC, Sinha R; HALT-C Trial Group.

Hepatology. 2009 Nov;50(5):1360-9.PMID: 19676128 [PubMed - in process]Related articles

Outcomes of patients with chest tube insertion for hepatic hydrothorax.

Orman ES, Lok AS.

Hepatol Int. 2009 Aug 11. [Epub ahead of print]PMID: 19669710 [PubMed - as supplied by publisher]Related articles

Myopathy and neuropathy associated with nucleos(t)ide analog therapy for hepatitis B.

Fleischer RD, Lok AS.

J Hepatol. 2009 Oct;51(4):787-91. Epub 2009 Jul 1.PMID: 19665816 [PubMed - in process]Related articles

An intention-to-treat analysis of liver transplantation for hepatocellular carcinoma using organ procurement transplant network data.

Pelletier SJ, Fu S, Thyagarajan V, Romero-Marrero C, Batheja MJ, Punch JD, Magee JC, Lok AS, Fontana RJ, Marrero JA.

Liver Transpl. 2009 Aug;15(8):859-68.PMID: 19642139 [PubMed - in process]Related articles

Hepatitis B virus variants.

Chotiyaputta W, Lok AS.

Nat Rev Gastroenterol Hepatol. 2009 Aug;6(8):453-62. Epub 2009 Jul 7. Review.PMID: 19581904 [PubMed - indexed for MEDLINE]Related articles

Hepatitis B: liver fibrosis and hepatocellular carcinoma.

Lok AS.

Gastroenterol Clin Biol. 2009 Oct-Nov;33(10-11):911-5. Epub 2009 Jul 4.PMID: 19577871 [PubMed - in process]Related articles

Weight-related effects on disease progression in the hepatitis C antiviral long-term treatment against cirrhosis trial.

Everhart JE, Lok AS, Kim HY, Morgan TR, Lindsay KL, Chung RT, Bonkovsky HL, Ghany MG; HALT-C Trial Group.

Gastroenterology. 2009 Aug;137(2):549-57. Epub 2009 May 13.PMID: 19445938 [PubMed - indexed for MEDLINE]Related articles

Evolution of nucleoside/tide analogues for hepatitis B: is the ideal drug here yet?

Lok AS.

J Hepatol. 2009 Aug;51(2):416-8. Epub 2009 Mar 27. No abstract available. PMID: 19410323 [PubMed]Related articles

Clinical decisions. Management of incidental hepatitis C virus infection.

Afdhal NH, Lok AS, Di Bisceglie AM.

N Engl J Med. 2009 Apr 30;360(18):1902-6. No abstract available. PMID: 19403909 [PubMed - indexed for MEDLINE]Related articles

Indications for therapy in hepatitis B.

Degertekin B, Lok AS.

Hepatology. 2009 May;49(5 Suppl):S129-37.PMID: 19399799 [PubMed - indexed for MEDLINE]Related articles

Update on viral hepatitis: 2008.

Degertekin B, Lok AS.

Curr Opin Gastroenterol. 2009 May;25(3):180-5. Review.PMID: 19387254 [PubMed - indexed for MEDLINE]Related articles

Alpha-fetoprotein, des-gamma carboxyprothrombin, and lectin-bound alpha-fetoprotein in early hepatocellular carcinoma.

Marrero JA, Feng Z, Wang Y, Nguyen MH, Befeler AS, Roberts LR, Reddy KR, Harnois D, Llovet JM, Normolle D, Dalhgren J, Chia D, Lok AS, Wagner PD, Srivastava S, Schwartz M.

Gastroenterology. 2009 Jul;137(1):110-8. Epub 2009 Apr 9.PMID: 19362088 [PubMed - indexed for MEDLINE]Related articles

Evolution of hepatic steatosis in patients with advanced hepatitis C: results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.

Lok AS, Everhart JE, Chung RT, Kim HY, Everson GT, Hoefs JC, Greenson JK, Sterling RK, Lindsay KL, Lee WM, Di Bisceglie AM, Bonkovsky HL, Ghany MG, Morishima C; HALT-C Trial Group.

Hepatology. 2009 Jun;49(6):1828-37.PMID: 19291787 [PubMed - indexed for MEDLINE]Related articles

Characterization of genotype-specific carboxyl-terminal cleavage sites of hepatitis B virus e antigen precursor and identification of furin as the candidate enzyme.

Ito K, Kim KH, Lok AS, Tong S.

J Virol. 2009 Apr;83(8):3507-17. Epub 2009 Feb 4.PMID: 19193799 [PubMed - indexed for MEDLINE]Related articlesFree article

Do guidelines preclude hepatitis B patients from receiving treatment?

Degertekin B, Lok AS.

Hepatology. 2009 Feb;49(2):700-1; author reply 701-2. No abstract available. PMID: 19177583 [PubMed - indexed for MEDLINE]Related articles

Role of antiviral therapy in the prevention of perinatal transmission of hepatitis B virus infection.

Chotiyaputta W, Lok AS.

J Viral Hepat. 2009 Feb;16(2):91-3. Epub 2008 Oct 8. No abstract available. PMID: 19175877 [PubMed - indexed for MEDLINE]Related articles

What is the optimal regimen for preventing hepatitis B recurrence after liver transplantation?

Degertekin B, Lok AS.

Nat Clin Pract Gastroenterol Hepatol. 2009 Feb;6(2):68-9. Epub 2008 Dec 17.PMID: 19092788 [PubMed - indexed for MEDLINE]Related articles

Is family history of liver cancer a risk factor for hepatocellular carcinoma?

Volk ML, Lok AS.

J Hepatol. 2009 Feb;50(2):247-8. Epub 2008 Dec 4. No abstract available. PMID: 19070916 [PubMed - indexed for MEDLINE]Related articles

Serum fibrosis marker levels decrease after successful antiviral treatment in chronic hepatitis C patients with advanced fibrosis.

Fontana RJ, Bonkovsky HL, Naishadham D, Dienstag JL, Sterling RK, Lok AS, Su GL; Halt-C Trial Group.

Clin Gastroenterol Hepatol. 2009 Feb;7(2):219-26. Epub 2008 Nov 7.PMID: 19068241 [PubMed - indexed for MEDLINE]Related articles

Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon.

Di Bisceglie AM, Shiffman ML, Everson GT, Lindsay KL, Everhart JE, Wright EC, Lee WM, Lok AS, Bonkovsky HL, Morgan TR, Ghany MG, Morishima C, Snow KK, Dienstag JL; HALT-C Trial Investigators.

N Engl J Med. 2008 Dec 4;359(23):2429-41.PMID: 19052125 [PubMed - indexed for MEDLINE]Related articlesFree article

Sensitivity and accuracy of an updated line probe assay (HBV DR v.3) in detecting mutations associated with hepatitis B antiviral resistance.

Degertekin B, Hussain M, Tan J, Oberhelman K, Lok AS.

J Hepatol. 2009 Jan;50(1):42-8. Epub 2008 Nov 5.PMID: 19019484 [PubMed - indexed for MEDLINE]Related articles

Impact of the model for end-stage liver disease allocation policy on the use of high-risk organs for liver transplantation.

Volk ML, Lok AS, Pelletier SJ, Ubel PA, Hayward RA.

Gastroenterology. 2008 Nov;135(5):1568-74.PMID: 19009713 [PubMed - indexed for MEDLINE]Related articles

Recipient morbidity after living and deceased donor liver transplantation: findings from the A2ALL Retrospective Cohort Study.

Freise CE, Gillespie BW, Koffron AJ, Lok AS, Pruett TL, Emond JC, Fair JH, Fisher RA, Olthoff KM, Trotter JF, Ghobrial RM, Everhart JE; A2ALL Study Group.

Am J Transplant. 2008 Dec;8(12):2569-79. Epub 2008 Oct 24.PMID: 18976306 [PubMed - indexed for MEDLINE]Related articles

Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease.

Lok AS, Seeff LB, Morgan TR, di Bisceglie AM, Sterling RK, Curto TM, Everson GT, Lindsay KL, Lee WM, Bonkovsky HL, Dienstag JL, Ghany MG, Morishima C, Goodman ZD; HALT-C Trial Group.

Gastroenterology. 2009 Jan;136(1):138-48. Epub 2008 Sep 18.PMID: 18848939 [PubMed - indexed for MEDLINE]Related articles

Should liver biopsies be performed on all hepatitis B carriers?

Degertekin B, Lok AS.

Gastroenterology. 2008 Nov;135(5):1802; author reply 1802-3. Epub 2008 Oct 7. No abstract available. PMID: 18840439 [PubMed - indexed for MEDLINE]Related articles

Re-weighting the model for end-stage liver disease score components.

Sharma P, Schaubel DE, Sima CS, Merion RM, Lok AS.

Gastroenterology. 2008 Nov;135(5):1575-81. Epub 2008 Aug 15.PMID: 18835388 [PubMed - indexed for MEDLINE]Related articles

How to diagnose and treat hepatitis B virus antiviral drug resistance in the liver transplant setting.

Lok AS.

Liver Transpl. 2008 Oct;14 Suppl 2:S8-S14. Review.PMID: 18825720 [PubMed - indexed for MEDLINE]Related articlesFree article

Impact of the hepatitis B virus genotype on pre- and post-liver transplantation outcomes.

Gaglio P, Singh S, Degertekin B, Ishitani M, Hussain M, Perrillo R, Lok AS; National Institutes of Health Hepatitis B Virus-Orthotopic Liver Transplantation Study Group.

Liver Transpl. 2008 Oct;14(10):1420-7.PMID: 18825703 [PubMed - indexed for MEDLINE]Related articlesFree article

Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.

Morishima C, Morgan TR, Everhart JE, Wright EC, Apodaca MC, Gretch DR, Shiffman ML, Everson GT, Lindsay KL, Lee WM, Lok AS, Dienstag JL, Ghany MG, Curto TM; HALT-C Trial Group.

Hepatology. 2008 Nov;48(5):1412-9.PMID: 18816437 [PubMed - indexed for MEDLINE]Related articles

Outcomes of living donor liver transplantation for acute liver failure: the adult-to-adult living donor liver transplantation cohort study.

Campsen J, Blei AT, Emond JC, Everhart JE, Freise CE, Lok AS, Saab S, Wisniewski KA, Trotter JF; Adult-to-Adult Living Donor Liver Transplantation Cohort Study Group.

Liver Transpl. 2008 Sep;14(9):1273-80.PMID: 18756453 [PubMed - indexed for MEDLINE]Related articlesFree article

Beyond utilitarianism: a method for analyzing competing ethical principles in a decision analysis of liver transplantation.

Volk ML, Lok AS, Ubel PA, Vijan S.

Med Decis Making. 2008 Sep-Oct;28(5):763-72. Epub 2008 Aug 25.PMID: 18725405 [PubMed - indexed for MEDLINE]Related articles

Changes in mood states and biomarkers during peginterferon and ribavirin treatment of chronic hepatitis C.

Fontana RJ, Kronfol Z, Lindsay KL, Bieliauskas LA, Padmanabhan L, Back-Madruga C, Lok AS, Stoddard AM; HALT-C Trial Group.

Am J Gastroenterol. 2008 Nov;103(11):2766-75. Epub 2008 Aug 21.PMID: 18721241 [PubMed - indexed for MEDLINE]Related articles

Monitoring antiviral resistance in patients receiving nucleos(t)ide analog therapies for hepatitis B: which method should be used?

Degertekin B, Lok AS.

J Hepatol. 2008 Jun;48(6):892-4. Epub 2008 Apr 1. No abstract available. PMID: 18433924 [PubMed - indexed for MEDLINE]Related articles

Update on viral hepatitis: 2007.

Degertekin B, Lok AS.

Curr Opin Gastroenterol. 2008 May;24(3):306-11. Review.PMID: 18408458 [PubMed - indexed for MEDLINE]Related articles

Prevalence and significance of occult hepatitis B in a liver transplant population with chronic hepatitis C.

Shetty K, Hussain M, Nei L, Reddy KR, Lok AS.

Liver Transpl. 2008 Apr;14(4):534-40.PMID: 18324677 [PubMed - indexed for MEDLINE]Related articlesFree article

Blunted cytopenias and weight loss: new correlates of virologic null response to re-treatment of chronic hepatitis C.

Lindsay KL, Morishima C, Wright EC, Dienstag JL, Shiffman ML, Everson GT, Lok AS, Bonkovsky HL, Lee WM, Morgan TR, Ghany MG; HALT-C Trial.

Clin Gastroenterol Hepatol. 2008 Feb;6(2):234-41.PMID: 18237873 [PubMed - indexed for MEDLINE]Related articles

Tenofovir monotherapy is effective in hepatitis B patients with antiviral treatment failure to adefovir in the absence of adefovir-resistant mutations.

Tan J, Degertekin B, Wong SN, Husain M, Oberhelman K, Lok AS.

J Hepatol. 2008 Mar;48(3):391-8. Epub 2008 Jan 3.PMID: 18199519 [PubMed - indexed for MEDLINE]Related articles

Herbal product use by persons enrolled in the hepatitis C Antiviral Long-Term Treatment Against Cirrhosis (HALT-C) Trial.

Seeff LB, Curto TM, Szabo G, Everson GT, Bonkovsky HL, Dienstag JL, Shiffman ML, Lindsay KL, Lok AS, Di Bisceglie AM, Lee WM, Ghany MG; HALT-C Trial Group.

Hepatology. 2008 Feb;47(2):605-12.PMID: 18157835 [PubMed - indexed for MEDLINE]Related articles

Antiviral-resistant hepatitis B virus: can we prevent this monster from growing?

Zoulim F, Buti M, Lok AS.

J Viral Hepat. 2007 Nov;14 Suppl 1:29-36. Review.PMID: 17958640 [PubMed - indexed for MEDLINE]Related articles

Entecavir therapy for up to 96 weeks in patients with HBeAg-positive chronic hepatitis B.

Gish RG, Lok AS, Chang TT, de Man RA, Gadano A, Sollano J, Han KH, Chao YC, Lee SD, Harris M, Yang J, Colonno R, Brett-Smith H.

Gastroenterology. 2007 Nov;133(5):1437-44. Epub 2007 Aug 14.PMID: 17983800 [PubMed - indexed for MEDLINE]Related articles

Outcomes of patients with hepatitis B who developed antiviral resistance while on the liver transplant waiting list.

Osborn MK, Han SH, Regev A, Bzowej NH, Ishitani MB, Tran TT, Lok AS; NIH HBV-OLT Study Group.

Clin Gastroenterol Hepatol. 2007 Dec;5(12):1454-61. Epub 2007 Oct 31.PMID: 17977800 [PubMed - indexed for MEDLINE]Related articlesFree article

Modified Charlson comorbidity index for predicting survival after liver transplantation.

Volk ML, Hernandez JC, Lok AS, Marrero JA.

Liver Transpl. 2007 Nov;13(11):1515-20.PMID: 17969207 [PubMed - indexed for MEDLINE]Related articlesFree article